REG - CAP-XX Limited - Receipt of R&D tax credit

CAP-XXAnnouncement

Today 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251219:nRSS3002Ma&default-theme=true

RNS Number : 3002M  CAP-XX Limited  19 December 2025

19 December 2025

CAP-XX Limited

("CAP-XX" or "the Company")

Receipt of R&D tax credit

CAP-XX Limited (AIM: CPX), a global leader in supercapacitor technology, is
pleased to announce that, further to the Company's announcement of 7 November
2025, the Australian Tax Office has approved the Company's R&D tax credit
of A$1.75m and these funds have been received by the Company.

The Company's current cash position is A$2.97m.

For further information contact:

CAP-XX Limited

Dr Graham Cooley
(Chairman)
+61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Broker)

David Hart/Piers Shimwell (Corporate Finance)
 
            +44 (0) 20 3328 5656

Jos Pinnington/Tony Quirke (Sales and Corporate Broking)

 

Notes to Editors:

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat
supercapacitors and energy management systems used in portable and small-scale
electronic devices, and to an increasing extent, in larger applications such
as automotive and renewable energy. The unique feature of CAP-XX
supercapacitors is their very high-power density and high energy storage
capacity in a space-efficient prismatic package. These attributes are
essential in power-hungry consumer and industrial electronics and deliver
similar benefits in automotive and other transportation applications.

For more information about CAP-XX, visit www.cap-xx.com
(http://www.cap-xx.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEAEANFFESFFA



            Copyright 2019 Regulatory News Service, all rights reserved